Search

Displaying results 271 - 280 of 9687 in total
  1. Drug

    Ropivacaine

    go.drugbank.com/drugs/DB00296
    ApprovedInvestigational

    It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.[L42140]

    Synonyms: L-N-n-propylpipecolic acid-2,6-xylidideProducts: ROPIVACAINA MYLAN GENERICS
  2. Drug

    Cefadroxil

    go.drugbank.com/drugs/DB01140
    ApprovedInvestigationalVet approvedWithdrawn

    Long-acting, broad-spectrum, water-soluble, cephalexin derivative.

    Products: CEFADROXIL MERCK GENERICS, CEFADROXIL 1A PHARMA1000MG
  3. Drug

    Gemfibrozil

    go.drugbank.com/drugs/DB01241
    ApprovedInvestigational

    Gemfibrozil is a fibric acid agent, similar to [clofibrate], used to treat Type IIb, IV, and V hyperlipidemias. … [A185777,L8525] Gemfibrozil is not a first line treatment and is prescribed to patients who have not responded adequately to weight loss, diet, exercise, and other medications.

    Products: GEMFIBROZIL DOC GENERICI
  4. Drug

    Ranitidine

    go.drugbank.com/drugs/DB00863
    ApprovedWithdrawn

    Ranitidine is a commonly used drug, classified as a histamine H2-receptor antagonist, and belongs to the same drug class as [cimetidine] and [famotidine].

    Products: RANITIDINA DOC GENERICI, RANITIDINA MYLAN GENERICS
  5. Drug

    Ketoprofen

    go.drugbank.com/drugs/DB01009
    ApprovedInvestigationalVet approved

    Ketoprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties.

    Products: KETOPROFENE DOC GENERICI, KETOPROFENE SALE DI LISINA MYLAN GENERICS
  6. Indication

    Lymphadenopathy

    go.drugbank.com/conditions/DBCOND0006524
    Drugs: Interferon alfa-2b
    Synonyms: LA - Lymphadenopathy
  7. Drug

    Irbesartan

    go.drugbank.com/drugs/DB01029
    ApprovedInvestigational

    [L7456,L7459] It can also be used as part of a combination product with [hydrochlorothiazide] for patients not well controlled or not expected to be well controlled on monotherapy. … [L7459] Unlike angiotensin converting enzyme inhibitors, ARBs are not associated with a dry cough.[L7456,L7459] Irbesartan was granted FDA approval on 30 September 1997.[L7456,L7459]

    Mixtures: IRBESARTAN E IDROCLOROTIAZIDE MYLAN GENERICS, IRBESARTAN E IDROCLOROTIAZIDE MYLAN GENERICSProducts: IRBESARTAN DOC GENERICI, IRBESARTAN AL 75MG
  8. Drug

    Amiodarone

    go.drugbank.com/drugs/DB01118
    ApprovedInvestigational

    Amiodarone is a benzofuran derivative, anti-arrhythmic drug used commonly in a variety of settings.

    Categories: BSEP/ABCB11 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic IndexProducts: AMIODARONE MYLAN GENERICS, AMIODARON AL 200
  9. Drug

    Urea

    go.drugbank.com/drugs/DB03904
    ApprovedInvestigational

    A compound formed in the liver from ammonia produced by the deamination of amino acids.

    Mixtures: Ti-U-lac Lotion, Ti-U-lac HC LotionProducts: Rea Lo 39, Rea Lo 40
  10. Drug

    Rasagiline

    go.drugbank.com/drugs/DB01367
    ApprovedInvestigational

    Rasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases.

    Categories: Compounds used in a research, industrial, or household settingProducts: RASAGILINA DOC GENERICI, RASAGILIN AL 1 MG TAB